P2RY2
P2Y purinoceptor 2
Also known as: P2RY2_HUMAN, P2U
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P41231
- Gene
- P2RY2
- Ensembl
- ENSG00000175591
- Chromosome
- 11
- Canonical length
- 377 aa
- Protein class
- G-protein coupled receptors, Predicted membrane proteins, Transporters
- Subcellular location
- Cytosol
OverviewNCBI Gene
The product of this gene belongs to the family of P2 receptors, which is activated by extracellular nucleotides and subdivided into P2X ligand-gated ion channels and P2Y G-protein coupled receptors. This family has several receptor subtypes with different pharmacological selectivity, which overlaps in some cases, for various adenosine and uridine nucleotides. This receptor, found on many cell types, is activated by ATP and UTP and is reported to be overexpressed on some cancer cell types. It is involved in many cellular functions, such as proliferation, apoptosis and inflammation. Three transcript variants encoding the same protein have been identified for this gene. [provided by RefSeq, Mar 2013]
Canonical amino-acid sequenceUniProt
377 residues, UniProt reviewed canonical sequence.
>P41231|P2RY2
1 MAADLGPWND TINGTWDGDE LGYRCRFNED FKYVLLPVSY GVVCVPGLCL NAVALYIFLC
61 RLKTWNASTT YMFHLAVSDA LYAASLPLLV YYYARGDHWP FSTVLCKLVR FLFYTNLYCS
121 ILFLTCISVH RCLGVLRPLR SLRWGRARYA RRVAGAVWVL VLACQAPVLY FVTTSARGGR
181 VTCHDTSAPE LFSRFVAYSS VMLGLLFAVP FAVILVCYVL MARRLLKPAY GTSGGLPRAK
241 RKSVRTIAVV LAVFALCFLP FHVTRTLYYS FRSLDLSCHT LNAINMAYKV TRPLASANSC
301 LDPVLYFLAG QRLVRFARDA KPPTGPSPAT PARRRLGLRR SDRTDMQRIE DVLGSSEDSR
361 RTESTPAGSE NTKDIRLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against P2RY2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 47 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 47 nTPM
- tongue: 29 nTPM
- esophagus: 28 nTPM
- vagina: 18 nTPM
- bone marrow: 15 nTPM
- cervix: 12 nTPM
Single-cell type
- esophageal apical cells: 114 nCPM
- esophageal suprabasal cells: 69 nCPM
- esophageal basal cells: 30 nCPM
- myonuclei: 25 nCPM
- monocyte progenitors: 22 nCPM
- cytotrophoblasts: 21 nCPM
Immune cell
- eosinophil: 58 nTPM
- intermediate monocyte: 20 nTPM
- non-classical monocyte: 14 nTPM
- classical monocyte: 6.6 nTPM
- myeloid DC: 3.2 nTPM
- total PBMC: 2.5 nTPM
Brain region
- thalamus: 5.8 nTPM
- medulla oblongata: 4.6 nTPM
- midbrain: 4.3 nTPM
- hypothalamus: 4 nTPM
- pons: 3.7 nTPM
- basal ganglia: 3.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.91
- gnomAD pLI
- 0.08
- gnomAD missense Z
- 0.2
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- blood vessel diameter maintenance
- cellular response to ATP
- G protein-coupled purinergic nucleotide receptor signaling pathway
- G protein-coupled receptor signaling pathway
- intracellular monoatomic ion homeostasis
- phospholipase C-activating G protein-coupled receptor signaling pathway
- positive regulation of mucus secretion
Molecular functions
- A1 adenosine receptor binding
- G protein-coupled purinergic nucleotide receptor activity
- G protein-coupled UTP receptor activity
- signaling receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads P2RY2 as an antibody target. Whether an autoantibody or antibody against P2RY2 could matter depends on whether native P2RY2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
P2RY2 is annotated at the cell surface, where native P2RY2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label P2RY2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...